LixisenatideWeight LossSafety Rating 8/10
Primary research areaType 2 diabetes
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range20 mcg once daily
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Adlyxin)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Lixisenatide
Mechanism of action
Once-daily prandial GLP-1 receptor agonist
Safety profile
Nausea, headache, hypoglycemia risk · Approved for T2DM; GI side effects; well-characterized
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Lixisenatide below your target.
Related pages